Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Zosano Pharma Corporation (NASDAQ: ZSAN) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) concerning whether a series of statements by Zosano Pharma Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Zosano Pharma Corporation offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its Initial Public Offering (IPO).

On January 20, 2016, a year later, NASDAQ: ZSAN shares dropped to as low as $2.00 per share.

Based in Fremont, CA, and founded in 2006 Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company, which develops a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of various indications.

If you purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185